A researcher in a lab looking at a tablet.

ALK+ Blog/News

  • Patient Spotlight: Creating families after cancer

    Interviews with ALK Positive Members: Receiving a stage IV lung cancer diagnosis comes with a lot of decisions. If you are in your reproductive years (like many of our ALK-positive

    Read More

  • How do ALK TKIs affect pregnancy?

    Studies on ALK TKIs* and Pregnancy In 2016, there was a study reported by Dr. Ibiayi et. al. (Dr. Shaw’s group) on patients who were pregnant or had just given

    Read More

  • Living your best life with lung cancer, a personal story

    Taking Control of My Legacy By Erika Hlavacek On September 29, 2017, I was diagnosed with Stage IV ALK Positive NSCLC. I was a 42 year old mom, former airline

    Read More

  • Juggling a young family while dealing with a cancer diagnosis

    When someone receives a cancer diagnosis, the entire family is affected.  In this quick review, we highlight several aspects of juggling a family while dealing with a cancer diagnosis.  

    Read More

  • Lung Cancer Research Round Up: Brain Metastasis Radiation Options

    Radiation Options to Treat Brain Metastasis: Quick Review of WBR, SRS, and SFRT Nieder et. al. wrote an easy to understand paper on the management of patients with brain metastases

    Read More

  • Announcing $5,000 Scholarships for Children of Parents with Rare Lung Cancer

    $5000 SCHOLARSHIPS FOR CHILDREN OF PARENTS WITH RARE LUNG CANCER College scholarship enabled by the family of Regina Dieker Kay & ALK Positive   Washington DC, March 15th, 2020 –

    Read More

  • Patient Spotlight: Courtney Bloodworth & Leslie Trahan

    EDITORS NOTE: Sadly, Courtney Bloodworth passed away on April 21, 2023. She was a young wife and mother of two little boys. Her impact on our ALK+ community lives on

    Read More

  • $500,000 Research grant to combat cancer treatment resistance

    SAN CARLOS, Calif. and WASHINGTON, Feb. 6, 2020 /PRNewswire/ — ALK Positive (a patient-led group of 1,900+ lung cancer patients and caregivers in 50+ countries) and GO2 Foundation for Lung Cancer (a global lung cancer advocacy and education organization)

    Read More

  • LUNGevity and ALK Positive Inc. partner to fund $1 Million in Lung Cancer Research Awards

    LUNGevity and the ALK Positive Group Partner to Fund $1 Million in Lung Cancer Research Awards Collaboration for patient-driven research that has lifesaving potential FOR IMMEDIATE RELEASE Media Contact:  Linda

    Read More

  • Patient Spotlight: Kirk Smith, Athens, GA

    Patient and lung cancer advocate Kirk Smith from Athens, GA talks to us about living (and thriving) with stage 4 lung cancer. Read on for an interview packed full of

    Read More

  • Case Study: successful re-use of Brigatinib after Lorlatinib

    Case study: Successful re-use of Brigatinib after Lorlatinib The patient in this case study was diagnosed with ALK-positive lung cancer in 2005 and had disease progression on several occasions.  Chemotherapy

    Read More

  • ,

    Biomarker Testing, explained

    Ever wondered what biomarker testing really refers to and what it means for your treatment options? Read on for a simplified explanation of how biomarkers can drive cancer, how testing

    Read More